Robot vs. doctor: new study aims to improve lung biopsy accuracy
NCT ID NCT07277088
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new robot-assisted system to the standard manual method for taking a tissue sample (biopsy) from a lung nodule. The goal is to see if the robot is as safe and effective at diagnosing lung cancer or other conditions. About 158 adults with suspicious lung nodules will be randomly assigned to one of the two biopsy methods. The main focus is on how often the biopsy gives a clear diagnosis, along with procedure time and complication rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Chest Hospital
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which lung biopsy method is safer and more accurate?
- Light-Based blood test may spot lung cancer early
- Can a CT-Free navigation system pinpoint lung nodules with precision?
- Could a nebulized cocktail make lung scopes less Cough-Inducing?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- AI showdown: three computer models battle to predict lung cancer from CT scans